ATS 2023 Archives - Medical Conferences

Home > Pulmonology > ATS 2023

Read the full Report (pdf)

American Thoracic Society 19–24 May 2023 Washington DC, USA

TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH

Presented By

Prof. Robert Frantz, Mayo Clinic, MN, USA

Trial

Phase 2, TORREY

Conference

ATS 2023

Type

News article

12 June 2023 16:16

Practice-changing results for ensifentrine in COPD

Presented By

Prof. Antonio Anzueto, University of Texas Health San Antonio, TX, USA

Trial

Phase 3, ENHANCE-1, ENHANCE-2

Conference

ATS 2023

Type

News article

12 June 2023 16:10

Online First

Asthma

Vitamin D for asthma protection: what is the optimal timing?

Presented By

Dr Lourdes Ramirez, Brigham and Women’s Hospital, MA, USA

Trial

Phase 3, VDAART

Conference

ATS 2023

Type

News article

12 June 2023 16:15

Remarkable results for novel biologic therapy for asthma

Presented By

Dr Benjamin Suratt, Sanofi, NJ, USA

Trial

Phase 1

Conference

ATS 2023

Type

News article

12 June 2023 16:00

Success for fluticasone furoate plus vilanterol in uncontrolled asthma

Presented By

Dr Philippe Bareille, GSK, UK

Conference

ATS 2023

Type

News article

12 June 2023 00:00

COPD

Practice-changing results for ensifentrine in COPD

Presented By

Prof. Antonio Anzueto, University of Texas Health San Antonio, TX, USA

Trial

Phase 3, ENHANCE-1, ENHANCE-2

Conference

ATS 2023

Type

News article

12 June 2023 16:10

Alvelestat for AATD meets primary endpoints in phase 2 trial

Presented By

Prof. Robert Stockley, University Hospital Birmingham, UK

Trial

Phase 2, ASTRAEUS

Conference

ATS 2023

Type

News article

12 June 2023 16:08

Fewer exacerbations with dupilumab in COPD with type 2 inflammation

Presented By

Prof. Klaus Rabe, LungenClinic Grosshansdorf GmbH, Germany

Trial

Phase 3, BOREAS

Conference

ATS 2023

Type

News article

12 June 2023 16:05

New AATD therapy may alleviate treatment burden for patients

Presented By

Dr Brooks Kuhn, UC Davis School of Medicine, CA, USA

Trial

Phase 1

Conference

ATS 2023

Type

News article

12 June 2023 16:02

Efficient detection of AECOPD with at-home vital signs monitoring

Presented By

Mr Yann Le Guillou, Biosency, France

Conference

ATS 2023

Type

News article

12 June 2023 15:55

COVID-19

COVA trial: success for the investigational agent sarconeos in hospitalised COVID-19

Presented By

Dr Girish Balachandran Nair, Beaumont Hospital, MI, USA

Trial

Phase 3, COVA

Conference

ATS 2023

Type

News article

12 June 2023 15:57

Mitochondrial DNA levels predict COVID-19 severity

Presented By

Dr Marlene Cano, Washington University in Saint Louis, MO, USA

Conference

ATS 2023

Type

News article

12 June 2023 15:47

Other

Excellent results for C21 in idiopathic pulmonary fibrosis

Presented By

Prof. Toby Maher , Keck School of Medicine of USC, USA

Trial

Phase 2, AIR

Conference

ATS 2023

Type

News article

12 June 2023 16:24

Can camlipixant improve quality of life of patients with refractory chronic cough?

Presented By

Dr Lorcan McGarvey, Queen’s University Belfast, UK

Trial

Phase 2, SOOTHE

Conference

ATS 2023

Type

News article

12 June 2023 16:22

TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH

Presented By

Prof. Robert Frantz, Mayo Clinic, MN, USA

Trial

Phase 2, TORREY

Conference

ATS 2023

Type

News article

12 June 2023 16:16

Improving quality care in sepsis through machine learning models

Presented By

Dr Elizabeth Munroe, University of Michigan, MI, USA

Conference

ATS 2023

Type

News article

12 June 2023 15:49

Can information technology improve guideline adherence in sepsis care?

Presented By

Dr Daniel Leisman, Massachusetts General Hospital, MA, USA

Conference

ATS 2023

Type

News article

12 June 2023 15:45

Medical Conferences

ATS 2023

Featured articles

TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH

Practice-changing results for ensifentrine in COPD

CONTENTS

Online First

Asthma

Vitamin D for asthma protection: what is the optimal timing?

Remarkable results for novel biologic therapy for asthma

Success for fluticasone furoate plus vilanterol in uncontrolled asthma

COPD

Practice-changing results for ensifentrine in COPD

Alvelestat for AATD meets primary endpoints in phase 2 trial

Fewer exacerbations with dupilumab in COPD with type 2 inflammation

New AATD therapy may alleviate treatment burden for patients

Efficient detection of AECOPD with at-home vital signs monitoring

COVID-19

COVA trial: success for the investigational agent sarconeos in hospitalised COVID-19

Mitochondrial DNA levels predict COVID-19 severity

Other

Excellent results for C21 in idiopathic pulmonary fibrosis

Can camlipixant improve quality of life of patients with refractory chronic cough?

TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH

Improving quality care in sepsis through machine learning models

Can information technology improve guideline adherence in sepsis care?